Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$650M Sell
12,978,996
-263,184
-2% -$12.7M 0.01% 899
2025
Q3
$650M Sell
13,242,180
-471,109
-3% -$24.1M 0.01% 912
2025
Q2
$710M Sell
13,713,289
-93,224
-0.7% -$4.28M 0.01% 834
2025
Q1
$645M Sell
13,806,513
-185,772
-1% -$9.59M 0.01% 850
2024
Q4
$717M Sell
13,992,285
-58,931
-0.4% -$3.05M 0.01% 837
2024
Q3
$625M Sell
14,051,216
-299,126
-2% -$13.1M 0.01% 902
2024
Q2
$577M Sell
14,350,342
-535,968
-4% -$20.3M 0.01% 903
2024
Q1
$596M Sell
14,886,310
-204,568
-1% -$7.69M 0.01% 902
2023
Q4
$568M Sell
15,090,878
-234,473
-2% -$7.17M 0.01% 897
2023
Q3
$426M Buy
15,325,351
+21,267
+0.1% +$665K 0.01% 978
2023
Q2
$463M Sell
15,304,084
-376,009
-2% -$11M 0.01% 968
2023
Q1
$483M Buy
15,680,093
+323,504
+2% +$12.3M 0.01% 922
2022
Q4
$577M Buy
15,356,589
+359,635
+2% +$14.3M 0.02% 792
2022
Q3
$563M Buy
14,996,954
+170,332
+1% +$6.76M 0.02% 764
2022
Q2
$535M Buy
14,826,622
+189,245
+1% +$7.83M 0.02% 820
2022
Q1
$717M Buy
14,637,377
+207,867
+1% +$10.5M 0.02% 761
2021
Q4
$691M Buy
14,429,510
+619,629
+4% +$29.3M 0.02% 813
2021
Q3
$606M Buy
13,809,881
+139,157
+1% +$5.88M 0.02% 867
2021
Q2
$600M Buy
13,670,724
+309,710
+2% +$14.5M 0.01% 879
2021
Q1
$611M Buy
13,361,014
+367,749
+3% +$15.4M 0.02% 832
2020
Q4
$421M Buy
12,993,265
+260,618
+2% +$7.54M 0.01% 970
2020
Q3
$270M Sell
12,732,647
-730,735
-5% -$15.2M 0.01% 1073
2020
Q2
$276M Sell
13,463,382
-332,197
-2% -$6.43M 0.01% 1075
2020
Q1
$242M Buy
13,795,579
+325,676
+2% +$10M 0.01% 1028
2019
Q4
$528M Sell
13,469,903
-621,688
-4% -$22.8M 0.02% 793
2019
Q3
$504M Sell
14,091,591
-509,283
-3% -$18.3M 0.02% 780
2019
Q2
$511M Sell
14,600,874
-752,481
-5% -$26.2M 0.02% 785
2019
Q1
$528M Buy
15,353,355
+3,302,348
+27% +$121M 0.02% 751
2018
Q4
$386M Buy
12,051,007
+892,407
+8% +$33.7M 0.02% 834
2018
Q3
$511M Buy
11,158,600
+387,831
+4% +$19.5M 0.02% 792
2018
Q2
$569M Buy
10,770,769
+204,264
+2% +$10.9M 0.02% 705
2018
Q1
$528M Buy
10,566,505
+36,932
+0.4% +$1.86M 0.02% 733
2017
Q4
$505M Buy
10,529,573
+274,967
+3% +$13M 0.02% 751
2017
Q3
$472M Sell
10,254,606
-315,060
-3% -$13.7M 0.02% 751
2017
Q2
$468M Sell
10,569,666
-29,040
-0.3% -$1.22M 0.02% 734
2017
Q1
$435M Buy
10,598,706
+375,030
+4% +$15.6M 0.02% 773
2016
Q4
$420M Buy
10,223,676
+546,191
+6% +$20.1M 0.02% 735
2016
Q3
$315M Buy
9,677,485
+316,250
+3% +$9.93M 0.02% 830
2016
Q2
$271M Buy
9,361,235
+311,646
+3% +$9.46M 0.02% 878
2016
Q1
$262M Buy
9,049,589
+685,044
+8% +$19.6M 0.02% 863
2015
Q4
$271M Buy
8,364,545
+153,434
+2% +$4.89M 0.02% 838
2015
Q3
$243M Buy
8,211,111
+1,686
+0% +$51.7K 0.02% 882
2015
Q2
$253M Buy
8,209,425
+140,557
+2% +$4.06M 0.02% 911
2015
Q1
$226M Buy
8,068,868
+371,467
+5% +$10.1M 0.02% 969
2014
Q4
$209M Buy
7,697,401
+40,153
+0.5% +$1.01M 0.02% 951
2014
Q3
$181M Buy
7,657,248
+45,834
+0.6% +$1.1M 0.01% 989
2014
Q2
$186M Buy
7,611,414
+131,888
+2% +$3.08M 0.01% 1011
2014
Q1
$177M Buy
7,479,526
+253,058
+4% +$6.15M 0.01% 993
2013
Q4
$182M Buy
7,226,468
+240,480
+3% +$5.67M 0.02% 943
2013
Q3
$161M Buy
6,985,988
+1,460,709
+26% +$33.3M 0.02% 954
2013
Q2
$113M Buy
+5,525,279
New +$105M 0.01% 1091

Other funds holding SNV

Vanguard Group's SNV Position: Q4 2025 in Review

Vanguard Group reduced its Synovus (SNV) stake by 2% in Q4 2025, selling an estimated $12.7M and leaving 12,978,996 shares worth $650M. The position accounts for 0.01% of the portfolio, ranked #899.

Vanguard Group first reported a position in SNV in Q2 2013 and has held it in 51 quarters since. The position peaked at $717M in Q1 2022. 454 funds tracked by Wall St. Rank hold SNV as of Q4 2025.

  • Vanguard Group held 12,978,996 shares of Synovus worth $650M as of Q4 2025.
  • Vanguard Group sold 263,184 Synovus shares in Q4 2025, an estimated $12.7M.
  • Synovus made up 0.01% of Vanguard Group's portfolio in Q4 2025, its #899 holding.
  • Vanguard Group first reported a position in Synovus in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's Synovus position peaked at $717M in Q1 2022.
  • 454 funds tracked by Wall St. Rank held Synovus as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.